In a report published Friday, Cantor Fitzgerald Upgraded shares of Intuitive Surgical (NASDAQ: ISRG) and raises price target to $575 on attractive risk reward profile. Cantor Fitzgerald said that, “While we certainly understand investor concern over the words "FDA Probe," we see limited risk of this investigation materializing into significant pun